These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2905532)

  • 1. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
    Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
    Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors.
    Lever JR; Dannals RF; Wilson AA; Ravert HT; Scheffel U; Hoffman BJ; Hartig PR; Wong DF; Wagner HN
    Int J Rad Appl Instrum B; 1989; 16(7):697-704. PubMed ID: 2575605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors.
    Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR
    J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: a ligand for in vitro and in vivo studies of serotonin receptors.
    Lever JR; Scheffel UA; Musachio JL; Stathis M; Wagner HN
    Life Sci; 1991; 48(15):PL73-8. PubMed ID: 2011045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo study of central serotoninergic receptors in man using positron tomography].
    Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
    Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
    Hartig PR; Scheffel U; Frost JJ; Wagner HN
    Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
    Scheffel U; Lever JR; Stathis M; Ricaurte GA
    Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
    Nakada MT; Wieczorek CM; Rainbow TC
    Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
    Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
    Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
    Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.